Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
| NAV9/12/2024 | Chg.+0.6300 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 216.8800EUR | +0.29% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | 4.50 | 1.83 | -5.03 | 10.78 | 0.59 | 4.26 | -10.61 | -11.54 | 7.84 | 3.34 | 0.40 | +4.26% |
| 2016 | -23.30 | -4.50 | 3.68 | 3.70 | 5.38 | -8.64 | 12.35 | -2.51 | 3.83 | -12.88 | 9.14 | -3.00 | -20.47% |
| 2017 | 5.33 | 6.69 | -0.05 | 0.89 | -3.15 | 9.22 | 2.21 | 6.71 | 0.69 | -6.82 | -0.16 | 1.27 | +24.05% |
| 2018 | 6.44 | -4.86 | -2.41 | -3.43 | 4.27 | 0.55 | 4.17 | 3.82 | -2.27 | -14.27 | 3.77 | -8.62 | -14.03% |
| 2019 | 12.76 | 3.32 | -0.89 | -5.21 | -4.74 | 9.15 | -2.47 | -2.55 | -4.76 | 10.91 | 11.78 | 2.49 | +30.88% |
| 2020 | -5.47 | -1.64 | -5.49 | 12.16 | 9.41 | 1.19 | -3.05 | 0.74 | 0.56 | -2.77 | 9.29 | 2.82 | +17.10% |
| 2021 | 1.73 | -2.65 | -4.44 | 2.62 | -2.35 | 6.25 | -1.54 | 3.80 | -4.36 | 0.09 | -4.46 | 2.24 | -3.71% |
| 2022 | -10.71 | -1.69 | 5.75 | -7.90 | -4.17 | 3.06 | 4.53 | 1.25 | -2.38 | 6.14 | 5.87 | -3.28 | -5.21% |
| 2023 | 2.66 | -5.87 | 0.05 | 2.69 | -1.17 | 1.20 | -0.77 | -0.42 | -4.65 | -6.26 | 5.89 | 13.33 | +5.25% |
| 2024 | 1.37 | 1.17 | -0.16 | -6.40 | 3.63 | 5.48 | 6.17 | 1.57 | -1.70 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.34% | 16.46% | 17.44% | 20.13% | 22.57% |
| Sharpe ratio | 0.78 | 0.78 | 0.91 | -0.08 | 0.22 |
| Best month | +13.33% | +6.17% | +13.33% | +13.33% | +13.33% |
| Worst month | -6.40% | -6.40% | -6.40% | -10.71% | -10.71% |
| Maximum loss | -11.27% | -8.91% | -11.83% | -28.84% | -32.47% |
| Outperformance | +0.20% | - | +1.23% | -7.79% | -6.03% |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,266.2600 | +19.69% | +5.67% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,405.0400 | +18.52% | +21.53% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,651.6799 | +16.38% | +19.01% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,045.0800 | +23.12% | +17.32% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 238.5200 | +18.07% | +21.30% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 384.3800 | +17.03% | +23.28% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 352.9600 | +19.18% | +24.57% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 219.8200 | +17.35% | +3.71% | |
| Candriam Equities L Biotechnolog... | reinvestment | 163.9700 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 661.8300 | +21.28% | +12.18% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,227.4102 | +22.10% | +13.53% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,277.2200 | +22.25% | +13.94% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 216.8800 | +19.35% | +5.65% | |
| Candriam Equities L Biotech.R US... | reinvestment | 296.1900 | +22.81% | +16.44% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 226.7500 | +20.36% | +8.27% | |
| Candriam Equities L Biotechnolo... | reinvestment | 930.0800 | +21.73% | +13.57% | |
| Candriam Equities L Biotechnolog... | paying dividend | 849.3300 | +21.69% | +13.46% |
Performance
| YTD | +11.06% | ||
|---|---|---|---|
| 6 Months | +7.92% | ||
| 1 Year | +19.35% | ||
| 3 Years | +5.65% | ||
| 5 Years | +50.67% | ||
| 10 Years | - | ||
| Since start | +44.59% | ||
| Year | |||
| 2023 | +5.25% | ||
| 2022 | -5.21% | ||
| 2021 | -3.71% | ||
| 2020 | +17.10% | ||
| 2019 | +30.88% | ||
| 2018 | -14.03% | ||
| 2017 | +24.05% | ||
| 2016 | -20.47% | ||
| 2015 | +4.26% | ||
